Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: MAPP BIOPHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2020-09-30 to 2026-06-30
Current total value of award: $16413163
Description: THE PURPOSE OF THIS NO-COST MODIFICATION IS TO UPDATE ARTICLE G.7 INDIRECT COST RATE BASED ON DOCUMENTATION FROM NIH DATED AUGUST 2, 2024.